Regulation of EGFR: Stat3 signaling by Mig6 is required for metastatic outgrowth in triple-negative breast cancer

被引：0
|
作者：
Wendt, Mike K. [1 ]
Balanis, Nlkolas [1 ]
Schiermann, Barbara [1 ]
Carlin, Cathleen [1 ]
Schiemann, William [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/1538-7445.TIM2013-A17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A17
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Flubendazole targets STAT3 signaling and distant metasis in triple-negative breast cancer
    Oh, Eunhye
    Kim, Yoon-Jae
    Jang, Seojin
    Cho, Tae-Min
    Park, Soeun
    Park, Jung Min
    Park, Minsu
    Kim, Ji Young
    Seo, Jae Hong
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [2] EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
    Song, Xiang
    Liu, Zhaoyun
    Yu, Zhiyong
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 703 - 717
  • [3] The Antitumorigenic Function of EGFR in Metastatic Breast Cancer is Regulated by Expression of Mig6
    Wendt, Michael K.
    Williams, Whitney K.
    Pascuzzi, Pete E.
    Balanis, Nikolas G.
    Schiemann, Barbara J.
    Carlin, Cathleen R.
    Schiemann, William P.
    [J]. NEOPLASIA, 2015, 17 (01): : 124 - 133
  • [4] Treating estrogen receptor (ER)-negative and triple-negative breast cancer by targeting STAT3 signaling with putative STAT3 inhibitors.
    Kim, Hyejin
    Fricke, Doerte R.
    Xu, Jimin
    Chen, Haiying
    Zhou, Jia
    Shen, Qiang
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [5] Genomic regulation of invasion by STAT3 in triple negative breast cancer
    McDaniel, Joy M.
    Varley, Katherine E.
    Gertz, Jason
    Savic, Daniel S.
    Roberts, Brian S.
    Bailey, Sarah K.
    Shevde, Lalita A.
    Ramaker, Ryne C.
    Lasseigne, Brittany N.
    Kirby, Marie K.
    Newberry, Kimberly M.
    Partridge, E. Christopher
    Jones, Angela L.
    Boone, Braden
    Levy, Shawn E.
    Oliver, Patsy G.
    Sexton, Katherine C.
    Grizzle, William E.
    Forero, Andres
    Buchsbaum, Donald J.
    Cooper, Sara J.
    Myers, Richard M.
    [J]. ONCOTARGET, 2017, 8 (05) : 8226 - 8238
  • [6] TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers
    Shields, Benjamin J.
    Wiede, Florian
    Gurzov, Esteban N.
    Wee, Kenneth
    Hauser, Christine
    Zhu, Hong-Jian
    Molloy, Timothy J.
    O'Toole, Sandra A.
    Daly, Roger J.
    Sutherland, Robert L.
    Mitchell, Christina A.
    McLean, Catriona A.
    Tiganis, Tony
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (03) : 557 - 570
  • [7] Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
    Samanta, S.
    Sharma, V. M.
    Khan, A.
    Mercurio, A. M.
    [J]. ONCOGENE, 2012, 31 (44) : 4689 - 4697
  • [8] Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
    S Samanta
    V M Sharma
    A Khan
    A M Mercurio
    [J]. Oncogene, 2012, 31 : 4689 - 4697
  • [9] Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
    Oh, Eunhye
    Kim, Yoon-Jae
    An, Hyunsook
    Sung, Daeil
    Cho, Tae-Min
    Farrand, Lee
    Jang, Seojin
    Seo, Jae Hong
    Kim, Ji Young
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (08) : 1978 - 1993
  • [10] Anti-metastatic potential of pitavastatin in triple-negative breast cancer via targeting breast cancer stem-like properties and STAT3 signaling
    Ko, Dongmi
    Seo, Juyeon
    Kim, Seongjae
    Park, Soeun
    Park, Minsu
    Dal Nam, Kee
    Kang, Yong Koo
    Seock, Sora
    Jung, Eunsun
    Kim, Yoon-Jae
    Park, Jaeyoun
    Kim, Ji Young
    Seo, Jae Hong
    [J]. CANCER RESEARCH, 2023, 83 (07)
12345